HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Tums Ultra

This article was originally published in The Tan Sheet

Executive Summary

SmithKline Beecham TV commercial targeting Pepcid Complete claims, "Dose for dose, Tums Ultra neutralizes twice as much acid as Pepcid Complete's antacid yet the Pepcid costs almost four times as much as the Tums." The 30-second spot, entitled "Harry's Heartburn," depicts a man eating at a diner about to try Pepcid Complete. "What was it before it was complete?" the waitress asks. "Who knows, but they added an antacid so they call it complete," Harry replies. The waitress convinces Harry to take Tums and later asks if it worked. "Completely," Harry says. The commercial broke Jan. 9, a day after J&J/Merck launched two TV spots for the Pepcid line extension, the first antacid/H2 antagonist combo that offers short-term relief and long-lasting acid control ingredients in one dosage form (1"The Tan Sheet" Jan. 15, p. 18)

You may also be interested in...



Pepcid Complete Launch Backed By Extensive PR Campaign

A public relations campaign for J&J/Merck's Pepcid Complete began Jan. 8 with two television ads promoting the new product, launched at the beginning of the year.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS131312

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel